Rang	Name	Position
1	Dr. Jeffrey Marc Leiden M.D., Ph.D.	Executive Chairman
2	Dr. Reshma Kewalramani FASN, M.D.	CEO, President & Director
3	Mr. Charles F. Wagner Jr.	Executive VP, COO & CFO
4	Mr. Amit K. Sachdev J.D.	Executive VP & Chief Patient and External Affairs Officer
5	Dr. Ourania Tatsis Ph.D.	Executive VP & Chief Product Affairs Officer
6	Dr. Carmen Bozic M.D.	Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer
7	Ms. Kristen C. Ambrose CPA	Senior VP & Chief Accounting Officer
8	Dr. Mark Bunnage D.Phil	Executive VP & Chief Scientific Officer
9	Ms. Susie Lisa C.F.A.	Senior Vice President of Investor Relations
10	Ms. Joy Liu J.D.	EVP, Chief Legal Officer & Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Capital World Investors	10,30%	13,46 Mrd. USD
2	BlackRock Inc	9,46%	12,36 Mrd. USD
3	Capital Research Global Investors	7,69%	10,05 Mrd. USD
4	Vanguard Capital Management, LLC	6,51%	8,51 Mrd. USD
5	State Street Corp	4,63%	6,05 Mrd. USD
6	Amvescap Plc.	3,11%	4,07 Mrd. USD
7	JPMorgan Chase & Co	2,77%	3,63 Mrd. USD
8	Geode Capital Management, LLC	2,42%	3,17 Mrd. USD
9	Vanguard Portfolio Management, LLC	2,03%	2,65 Mrd. USD
10	Capital Research & Mgmt Co - Division 3	1,85%	2,42 Mrd. USD
11	Loomis, Sayles & Company LP	1,55%	2,02 Mrd. USD
12	AllianceBernstein L.P.	1,54%	2,02 Mrd. USD
13	Wellington Management Company LLP	1,28%	1,67 Mrd. USD
14	Morgan Stanley - Brokerage Accounts	1,26%	1,64 Mrd. USD
15	UBS Asset Mgmt Americas Inc	1,21%	1,58 Mrd. USD
16	Jennison Associates LLC	1,18%	1,55 Mrd. USD
17	NORGES BANK	1,17%	1,53 Mrd. USD
18	Bank of America Corp	1,14%	1,48 Mrd. USD
19	ClearBridge Advisors, LLC	1,07%	1,39 Mrd. USD
20	Ameriprise Financial Inc	1,04%	1,36 Mrd. USD